ID   BCAR3_RAT               Reviewed;         825 AA.
AC   D3ZAZ5;
DT   26-FEB-2020, integrated into UniProtKB/Swiss-Prot.
DT   20-APR-2010, sequence version 1.
DT   24-JUL-2024, entry version 104.
DE   RecName: Full=Breast cancer anti-estrogen resistance protein 3 homolog {ECO:0000305};
DE   AltName: Full=BCAR3 adapter protein, NSP family member {ECO:0000305};
DE   AltName: Full=Novel SH2-containing protein 2 {ECO:0000305};
DE   AltName: Full=SH2 domain-containing protein 3B {ECO:0000305};
DE   AltName: Full=p130Cas-binding protein AND-34 {ECO:0000305};
GN   Name=Bcar3 {ECO:0000312|RGD:1311688};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116 {ECO:0000312|Proteomes:UP000002494};
RN   [1] {ECO:0000312|Proteomes:UP000002494}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway {ECO:0000312|Proteomes:UP000002494};
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2] {ECO:0000312|EMBL:EDL82101.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0007744|PubMed:22673903}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [4] {ECO:0000305}
RP   FUNCTION, AND INTERACTION WITH BCAR1.
RX   PubMed=24216110; DOI=10.1016/j.bbrc.2013.10.161;
RA   Oh M.J., Yi S.J., Kim H.S., Kim J.H., Jeong Y.H., van Agthoven T.,
RA   Jhun B.H.;
RT   "Functional roles of BCAR3 in the signaling pathways of insulin leading to
RT   DNA synthesis, membrane ruffling and GLUT4 translocation.";
RL   Biochem. Biophys. Res. Commun. 441:911-916(2013).
CC   -!- FUNCTION: Acts as an adapter protein downstream of several growth
CC       factor receptors to promote cell proliferation, migration, and
CC       redistribution of actin fibers (By similarity). Specifically involved
CC       in INS/insulin signaling pathway by mediating MAPK1/ERK2-MAPK3/ERK1
CC       activation and DNA synthesis (PubMed:24216110). Promotes insulin-
CC       mediated membrane ruffling (PubMed:24216110). In response to
CC       vasoconstrictor peptide EDN1, involved in the activation of RAP1
CC       downstream of PTK2B via interaction with phosphorylated BCAR1 (By
CC       similarity). Inhibits cell migration and invasion via regulation of
CC       TGFB-mediated matrix digestion, actin filament rearrangement, and
CC       inhibition of invadopodia activity (By similarity). May inhibit
CC       TGFB/SMAD signaling, via facilitating BCAR1 and SMAD2 and/or SMAD3
CC       interaction (By similarity). Regulates EGF-induced DNA synthesis (By
CC       similarity). Required for the maintenance of ocular lens morphology and
CC       structural integrity, potentially via regulation of focal adhesion
CC       complex signaling (By similarity). Acts upstream of PTPRA to regulate
CC       the localization of BCAR1 and PTPRA to focal adhesions, via regulation
CC       of SRC-mediated phosphorylation of PTPRA (By similarity). Positively
CC       regulates integrin-induced tyrosine phosphorylation of BCAR1 (By
CC       similarity). Acts as a guanine nucleotide exchange factor (GEF) for
CC       small GTPases RALA, RAP1A and RRAS (By similarity). However, in a
CC       contrasting study, lacks GEF activity towards RAP1 (By similarity).
CC       {ECO:0000250|UniProtKB:O75815, ECO:0000250|UniProtKB:Q9QZK2,
CC       ECO:0000269|PubMed:24216110}.
CC   -!- SUBUNIT: Part of a complex comprised of PTPRA, BCAR1, BCAR3 and SRC;
CC       the formation of the complex is dependent on integrin mediated-tyrosine
CC       phosphorylation of PTPRA (By similarity). Within the complex, interacts
CC       (via SH2 domain) with PTPRA (when phosphorylated on 'Tyr-792') (By
CC       similarity). Interacts (via Ras-GEF domain) with BCAR1
CC       (PubMed:24216110). Interacts (via Ras-GEF domain) with NEDD9 (By
CC       similarity). Interacts with PTK2/FAK1 (By similarity). Interacts with
CC       PTPN1. Interacts (via SH2 domain) with EGFR (when tyrosine-
CC       phosphorylated) (By similarity). {ECO:0000250|UniProtKB:O75815,
CC       ECO:0000250|UniProtKB:Q9QZK2, ECO:0000269|PubMed:24216110}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9QZK2}. Cell
CC       junction, focal adhesion {ECO:0000250|UniProtKB:Q9QZK2}.
CC       Note=Localization to focal adhesions depends on interaction with PTPRA.
CC       {ECO:0000250|UniProtKB:Q9QZK2}.
CC   -!- DOMAIN: The SH2 domain mediates interaction with tyrosine-
CC       phosphorylated proteins (By similarity). However, not involved in the
CC       binding to phosphorylated BCAR1 (By similarity). Required for cell
CC       cycle progression in response to INS/insulin (By similarity). Required
CC       for regulation of EGF-induced DNA synthesis (By similarity).
CC       {ECO:0000250|UniProtKB:O75815, ECO:0000250|UniProtKB:Q9QZK2}.
CC   -!- DOMAIN: The Ras-GEF domain appears to adopt a closed conformation
CC       rendering it incapable of carrying out canonical exchange factor
CC       function, this closed conformation is probably required for interaction
CC       with BCAR1. {ECO:0000250|UniProtKB:O75815}.
CC   -!- PTM: Phosphorylated on tyrosine residues.
CC       {ECO:0000250|UniProtKB:Q9QZK2}.
CC   -!- CAUTION: The guanine nucleotide exchange factor (GEF) activity is
CC       controversial. One study showed GEF activity towards RALA, RAP1A and
CC       RRAS (By similarity). However, in another study, a construct containing
CC       only the Ras-GEF domain lacks GEF activity towards RAP1 (By
CC       similarity). {ECO:0000250|UniProtKB:O75815,
CC       ECO:0000250|UniProtKB:Q9QZK2}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR07013194; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07013195; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07013196; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07013197; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07013198; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07013199; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07013200; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH473952; EDL82101.1; -; Genomic_DNA.
DR   RefSeq; NP_001101192.1; NM_001107722.1.
DR   AlphaFoldDB; D3ZAZ5; -.
DR   SMR; D3ZAZ5; -.
DR   STRING; 10116.ENSRNOP00000062880; -.
DR   iPTMnet; D3ZAZ5; -.
DR   PhosphoSitePlus; D3ZAZ5; -.
DR   PaxDb; 10116-ENSRNOP00000062880; -.
DR   PeptideAtlas; D3ZAZ5; -.
DR   Ensembl; ENSRNOT00000065111.2; ENSRNOP00000062880.1; ENSRNOG00000013737.7.
DR   Ensembl; ENSRNOT00055046552; ENSRNOP00055038192; ENSRNOG00055026952.
DR   Ensembl; ENSRNOT00060004534; ENSRNOP00060003228; ENSRNOG00060002807.
DR   Ensembl; ENSRNOT00065036989; ENSRNOP00065029801; ENSRNOG00065021731.
DR   GeneID; 310838; -.
DR   KEGG; rno:310838; -.
DR   AGR; RGD:1311688; -.
DR   CTD; 8412; -.
DR   RGD; 1311688; Bcar3.
DR   eggNOG; ENOG502QPX3; Eukaryota.
DR   GeneTree; ENSGT00940000154130; -.
DR   HOGENOM; CLU_015281_0_0_1; -.
DR   InParanoid; D3ZAZ5; -.
DR   OMA; ILKMDCK; -.
DR   OrthoDB; 2953960at2759; -.
DR   TreeFam; TF323756; -.
DR   PRO; PR:D3ZAZ5; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Proteomes; UP000234681; Chromosome 2.
DR   Bgee; ENSRNOG00000013737; Expressed in jejunum and 20 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005925; C:focal adhesion; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0019900; F:kinase binding; ISO:RGD.
DR   GO; GO:0001784; F:phosphotyrosine residue binding; ISS:UniProtKB.
DR   GO; GO:0086100; P:endothelin receptor signaling pathway; ISO:RGD.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0002089; P:lens morphogenesis in camera-type eye; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; ISS:UniProtKB.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; ISO:RGD.
DR   GO; GO:0007264; P:small GTPase-mediated signal transduction; IEA:InterPro.
DR   CDD; cd10337; SH2_BCAR3; 1.
DR   Gene3D; 1.10.840.10; Ras guanine-nucleotide exchange factors catalytic domain; 1.
DR   Gene3D; 3.30.505.10; SH2 domain; 1.
DR   InterPro; IPR023578; Ras_GEF_dom_sf.
DR   InterPro; IPR001895; RASGEF_cat_dom.
DR   InterPro; IPR036964; RASGEF_cat_dom_sf.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR051853; SH2-Ras-GEF_adapter.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR044102; SH2_SHEP1/BCAR3/NSP1.
DR   PANTHER; PTHR14247:SF10; BREAST CANCER ANTI-ESTROGEN RESISTANCE PROTEIN 3; 1.
DR   PANTHER; PTHR14247; BREAST CANCER ANTI-ESTROGEN RESISTANCE PROTEIN 3 HOMOLOG-LIKE PROTEIN; 1.
DR   Pfam; PF00617; RasGEF; 1.
DR   Pfam; PF00017; SH2; 1.
DR   SMART; SM00147; RasGEF; 1.
DR   SMART; SM00252; SH2; 1.
DR   SUPFAM; SSF48366; Ras GEF; 1.
DR   SUPFAM; SSF55550; SH2 domain; 1.
DR   PROSITE; PS50009; RASGEF_CAT; 1.
DR   PROSITE; PS50001; SH2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cell junction; Cytoplasm; Guanine-nucleotide releasing factor;
KW   Methylation; Phosphoprotein; Reference proteome; SH2 domain.
FT   INIT_MET        1
FT                   /note="Removed"
FT   CHAIN           2..825
FT                   /note="Breast cancer anti-estrogen resistance protein 3
FT                   homolog"
FT                   /id="PRO_0000449050"
FT   DOMAIN          154..253
FT                   /note="SH2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   DOMAIN          548..818
FT                   /note="Ras-GEF"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00168"
FT   REGION          40..84
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          300..320
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          744..748
FT                   /note="Mediates the interaction with BCAR1/p130CAS"
FT                   /evidence="ECO:0000250|UniProtKB:O75815"
FT   COMPBIAS        69..84
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            748
FT                   /note="Required for interaction with NEDD9"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QZK2"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:O75815"
FT   MOD_RES         32
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O75815"
FT   MOD_RES         78
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O75815"
FT   MOD_RES         83
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O75815"
FT   MOD_RES         182
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O75815"
FT   MOD_RES         290
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O75815"
FT   MOD_RES         334
FT                   /note="N6-methyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O75815"
FT   MOD_RES         358
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O75815"
FT   MOD_RES         363
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O75815"
FT   MOD_RES         375
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QZK2"
FT   MOD_RES         442
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:O75815"
FT   MOD_RES         471
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QZK2"
SQ   SEQUENCE   825 AA;  92477 MW;  473EA12F02A892E1 CRC64;
     MAAGKFASLP RHMPVNHQFP LASSMDLLSS KSPLAEHRTE AYPDVSIHGT LPRKKKGPPP
     IRSCDSASHM GTLPHSKSPR QSSPLTQDLI LEKPLPDWKG DSFAFRDPYL LDPTLEYVKF
     SKERHIMDRT PERLKKELEE ELLLSSEDLR SHAWYHGRIP RQVSENLVQR DGDFLVRDSL
     SSPGNFVLTC QWKNLAQHFK INRTVLRLSE AYSRVQYQFE MESFDSIPGL VRCYVGNRRP
     ISQQSGAIIF QPINRTVPLW CLEERYGTSP GRGREGSFAE GRPDVVKRLS LTTGGIQARD
     HSLPRGNLLR NKDKSGSQPA CLDHVQDRKA ATLKAHQSES HLPIGCKLPP QSPSVDTSPC
     PNSPVFRTGS EPTLSPALVR RFSSDARAGE ALRGSDSQLC PKPPPKPCKV PFLKVPPSPS
     PWLNSEANYC ELNPAFAVGC DRGAKLLSQA LDSHEMLLTA KQNGASGPRN SGINYSILDG
     DDQGRHWDPL AVQTDEGQED ETKFVPPVME TVSSFRPNDF ESKLLPPENK PLETAMLKHA
     KELFTNHDAR VIAQHMLSVD CKVARILEVS EDMKRSMGVS SGLELITLPH GRQLRLDIIE
     RHNTMAIGIA VDILGCTGTL ENRAGTLNKI IQVAMELKDT MGDLYSFSAI MKALEMPQIT
     RLEKTWTALR HHYTQTAILY EKQLKPFSKI LHEGRESTYV PASSVSVPLL MPLVTLMERQ
     AVTFEGTDMW EKNDESCEIM LSHLATARFM AEASESYRMN AERVLADFQP DEEMTEILKT
     EFQMRLLWGS KGAEVNQNER YDKFNQILTA LSRKLEPPSG KQAEL
//
